Kearny Venture Partners
Venture Capital & Private Equity, 88 Kearny St, San Francisco, California, 94108, United States, 1-10 Employees
Phone Number: +12*********
Who is KEARNY VENTURE PARTNERS
With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entre...
Read More
-
Headquarters: 88 Kearny St, San Francisco, California, 94108, United States
-
Date Founded: 1900
-
Employees: 1-10
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Venture Capital & Private Equity
SIC Code: 6771
|
NAICS Code: 523910 |
Show More
Does something look wrong? Fix it. | View contact records from KEARNY VENTURE PARTNERS
Kearny Venture Partners Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Kearny Venture Partners
Answer: Kearny Venture Partners's headquarters are located at 88 Kearny St, San Francisco, California, 94108, United States
Answer: Kearny Venture Partners's phone number is +12*********
Answer: Kearny Venture Partners's official website is https://kearnyvp.com
Answer: Kearny Venture Partners's revenue is $5 Million to $10 Million
Answer: Kearny Venture Partners's SIC: 6771
Answer: Kearny Venture Partners's NAICS: 523910
Answer: Kearny Venture Partners has 1-10 employees
Answer: Kearny Venture Partners is in Venture Capital & Private Equity
Answer: Kearny Venture Partners contact info: Phone number: +12********* Website: https://kearnyvp.com
Answer: With over $330 million in capital under management, Kearny Venture Partners is a venture capital firm exclusively focused on healthcare products. We believe that the opportunity for entrepreneurs to devise innovative solutions in healthcare has never been greater. Significant unmet needs in healthcare continue to persist, representing large potential market opportunities for safe and effective products. As the molecular basis of disease is increasingly unraveled, new opportunities for intervention emerge. Novel therapies can and will displace incumbent products.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month